SuperTrans Medical is a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multidrug-resistant bacteria often known as superbugs.
The companys guanidinium-rich molecular transporter (GR-MoTr) technology used in conjunction with existing FDA-approved antibiotics results in superior antimicrobial properties.
SuperTrans Medical is committed to an expedited development program and a shorter path to the clinic.
Cumulative Funding Raised Over Time ($)
Employees Over Time
SuperTrans Medical Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 16, 2021
en.prnasia.com
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria
#Investment
Mar 15, 2021
www.prnewswire.com
SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria
#Investment
Mar 15, 2021
www.prnewswire.com
SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria